SE7711039L - Nya 9-klorprednisolonderivat och sett att framstella desamma - Google Patents

Nya 9-klorprednisolonderivat och sett att framstella desamma

Info

Publication number
SE7711039L
SE7711039L SE7711039A SE7711039A SE7711039L SE 7711039 L SE7711039 L SE 7711039L SE 7711039 A SE7711039 A SE 7711039A SE 7711039 A SE7711039 A SE 7711039A SE 7711039 L SE7711039 L SE 7711039L
Authority
SE
Sweden
Prior art keywords
derivatives
chloroprednisolon
produce
new
way
Prior art date
Application number
SE7711039A
Other languages
Unknown language ( )
English (en)
Other versions
SE431655B (sv
Inventor
K Annen
H Laurent
H Hofmeister
R Wiechert
H Wendt
J F Kapp
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2645105A external-priority patent/DE2645105C2/de
Priority claimed from DE19772742982 external-priority patent/DE2742982C2/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of SE7711039L publication Critical patent/SE7711039L/sv
Publication of SE431655B publication Critical patent/SE431655B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7711039A 1976-10-04 1977-10-03 Analogiforfaranden for framstellning av nya 9-klorprednisolon-derivat SE431655B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2645105A DE2645105C2 (de) 1976-10-04 1976-10-04 Derivate des 9-Chlorprednisolons, Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Präparat
DE19772742982 DE2742982C2 (de) 1977-09-21 1977-09-21 9-Chlorprednisolon-Derivate, Verfahren zu deren Herstellung und diese enthaltendes pharmazeutisches Präparat

Publications (2)

Publication Number Publication Date
SE7711039L true SE7711039L (sv) 1978-04-05
SE431655B SE431655B (sv) 1984-02-20

Family

ID=25770978

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7711039A SE431655B (sv) 1976-10-04 1977-10-03 Analogiforfaranden for framstellning av nya 9-klorprednisolon-derivat

Country Status (21)

Country Link
JP (1) JPS5359654A (sv)
AT (1) AT358202B (sv)
CH (4) CH630098A5 (sv)
DK (1) DK438277A (sv)
ES (1) ES462887A1 (sv)
FI (1) FI58645C (sv)
FR (1) FR2366313A1 (sv)
GB (1) GB1594852A (sv)
GR (1) GR73041B (sv)
HU (1) HU179593B (sv)
IE (1) IE45877B1 (sv)
IL (1) IL53030A (sv)
IT (1) IT1113623B (sv)
LU (1) LU78223A1 (sv)
NL (1) NL7710869A (sv)
NO (1) NO148597C (sv)
NZ (1) NZ185295A (sv)
PL (1) PL110392B1 (sv)
PT (1) PT67109B (sv)
SE (1) SE431655B (sv)
SU (2) SU743581A3 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2853785A1 (de) * 1978-12-11 1980-06-19 Schering Ag Neue prednison-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische praeparate und deren verwendung
JPH0374245A (ja) * 1989-08-12 1991-03-28 Mk Seiko Co Ltd 洗車機
AU2011231543B2 (en) 2010-03-26 2015-01-15 Galderma Research & Development Improved methods and compositions for safe and effective treatment of erythema
US9744168B2 (en) 2011-10-19 2017-08-29 Galderma Laboratories, Inc. Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors
CN106632561A (zh) * 2016-12-16 2017-05-10 广州仁恒医药科技股份有限公司 一种二氟泼尼酯的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1195748B (de) * 1961-06-24 1965-07-01 Vismara Francesco Spa Verfahren zur Herstellung von 1'-substituierten 17alpha, 21-(1'-Alkoxy)-methylendioxysterioden
DE2055221A1 (en) * 1970-11-10 1972-05-18 Laboratorio Chimico Farmaceutico Dr. P. Blasina S.R.L., Mailand (Italien) 17-acyloxy-3-keto-pregn-4-enes prepn - by acylating 17-hydroxy steroids in presence ofstannic chloride

Also Published As

Publication number Publication date
ATA703577A (de) 1980-01-15
FI58645B (fi) 1980-11-28
FI772922A (fi) 1978-04-05
FI58645C (fi) 1981-03-10
HU179593B (en) 1982-11-29
NO148597C (no) 1983-11-09
NO773362L (no) 1978-04-05
PT67109A (de) 1977-11-01
GR73041B (sv) 1984-01-26
SE431655B (sv) 1984-02-20
NZ185295A (en) 1980-04-28
CH630098A5 (en) 1982-05-28
PL110392B1 (en) 1980-07-31
SU743581A3 (ru) 1980-06-25
AT358202B (de) 1980-08-25
PT67109B (de) 1979-03-14
IL53030A (en) 1982-11-30
NL7710869A (nl) 1978-04-06
GB1594852A (en) 1981-08-05
IE45877L (en) 1978-04-04
SU751327A3 (ru) 1980-07-23
IE45877B1 (en) 1982-12-15
DK438277A (da) 1978-04-05
PL201161A1 (pl) 1979-01-29
IT1113623B (it) 1986-01-20
FR2366313A1 (fr) 1978-04-28
FR2366313B1 (sv) 1980-02-01
ES462887A1 (es) 1978-12-16
LU78223A1 (sv) 1978-02-01
CH632278A5 (en) 1982-09-30
CH632772A5 (en) 1982-10-29
CH631997A5 (en) 1982-09-15
JPS6129960B2 (sv) 1986-07-10
NO148597B (no) 1983-08-01
IL53030A0 (en) 1977-11-30
JPS5359654A (en) 1978-05-29

Similar Documents

Publication Publication Date Title
DK374083A (da) Cyclovitamin-d forbindelser
ATE24001T1 (de) Substituierte 1-hydroxyethyl-triazolyl-derivate.
ES461620A1 (es) Procedimiento para la obtencion de eteres benzoilureido- difenilicos.
SE8104132L (sv) Mjuka steroider med antiiflammatorisk verkan
LU88289I2 (fr) Methylprednisolonaceponate (Advantan)
ES474666A1 (es) Procedimiento para la preparacion de alcohil-sulfato-betai- nas que contienen fluor
FI832575A (fi) Nya 6,16-dimetylkortikoider, deras framstaellning och anvaendning
JPS5331676A (en) Uracil derivatives and their preparation
SE7711039L (sv) Nya 9-klorprednisolonderivat och sett att framstella desamma
IL66152A0 (en) Pyridinocarbinols,their preparation and their use as fungicides
SE7707173L (sv) Nya joderade isoftalamsyraderivat och sett att framstella desamma
SE7713704L (sv) Propionsyraderivat och sett for framstellning av desamma
GR79170B (sv)
ES460807A1 (es) Procedimiento para la produccion de compuestos de isoindoli-nona.
EP0044266A3 (en) Substituted 3,5-diamino-1,2,4-oxadiazoles and 3,5-diamino-1,2,4-thiadiazoles, their preparation and use
FR2549475B1 (fr) Nouveaux derives de benzofuranne, leur preparation et leur utilisation therapeutique
JPS535162A (en) Novel imidazole derivatives
SE7708452L (sv) Komposition innehallande en antrakinonforening
JPS5334764A (en) Preparation of diterpene derivatives and their preparation
DE3369324D1 (en) Thiolphosphoric-acid esters, their preparation and use
JPS52147649A (en) Ultraviolet light absorbers with low volatility
SE7612960L (sv) Tienamycinderivat
SE7706693L (sv) Sett att framstella hydrazinopyridazinderivat
AU529684B2 (en) Organic compounds
JPS5334785A (en) 1-substituted-4-halogeno-5, 6, 7, 8-tetrahydrophthalazines

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7711039-3

Effective date: 19880627

Format of ref document f/p: F